Skip to content
healthcare.dev

Bactine Max

NDC 65197-811, benzalkonium chloride and lidocaine hydrochloride, liquid, from WellSpring Pharmaceutical Corporation.

Product NDC
65197-811
Status
Listed
Labeler
WellSpring Pharmaceutical Corporation
Dosage form
LIQUID
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M003
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65197-811 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENZALKONIUM CHLORIDE.13 g/100mL
  • LIDOCAINE HYDROCHLORIDE4 g/100mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
65197-811-1465197081114118 mL in 1 BOTTLE, PLASTIC (65197-811-14)
65197-811-1565197081115148 mL in 1 BOTTLE (65197-811-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 65197-811 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65197-811 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65197-811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.